Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarung nach § 130a Abs. 8 bzw. § 130c Abs. 8 SGB V zu patentgeschützten Wirkstoffen-VV93
Description
Section 130a Paragraph 8 and Section 130c Paragraph 8 of the German Social Code Book V (SGB V) allow health insurers (KK) and pharmaceutical companies to conclude framework agreements on the prescription drugs to be dispensed at the expense of the statutory health insurers. The GWQ acts as the Society for Economy and Quality with KK according to Section 130a Paragraph 8 Sentence 5 SGB V for its shareholder and customer insurers. With regard to the relevant legal provisions for the award of public contracts, a regular process of substance-related, formal tendering procedures according to the regulations of Part 4 of the GWB is carried out by the GWQ ServicePlus AG. The contract start date is 01.10.2026.
CPV codes
Documents & submission
Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.
Related tenders
Germany – Miscellaneous medical devices and products – VE 473.05 105 Deckenversorgungseinheiten Medien
Universitätsklinikum HeidelbergGermanyMiscellaneous medical devices and productsInstallation services of medical equipmentDeadline in 29 daysPublished on Nov 19, 2026
Germany – Pharmaceutical products – Arzneimittelverträge mit Beitrittsoption
BARMER Beschaffung und VergabeGermanyPharmaceutical productsDeadline in 620 daysPublished on Nov 19, 2026
Germany – Medical equipments, pharmaceuticals and personal care products – Absaugung, Invasive Blutdruckmessung und Regionalanästhesie
EK-UNICO GmbHGermanyMedical equipments, pharmaceuticals and personal care productsVenepuncture, blood sampling devicesAnaesthesia and resuscitationDeadline in 32 daysPublished on Nov 19, 2026
Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Aflibercept, ausgenommen 114,3 mg/ml (ATC-Code: S01LA05).
AOK Niedersachsen. Die Gesundheitskasse.GermanyPharmaceutical productsDeadline in 707 daysPublished on Nov 19, 2026